- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
API Nanotronics Corp. (OTCBB: APIO) ("API") (the "Company"), a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, announced today that its Chief Technology Officer, Dr. Martin Moskovits, was invited to present at the NASA Tech Briefs National Nano Engineering Conference 2007.
This prestigious event is focused on current and future developments in engineering innovations at the nanoscale, as well as the commercialization of nanotechnology. This year the event will be held November 14 & 15th at the Boston Marriott Copley Place. A variety of leaders in the scientific community will be speaking on developments in different fields of nanotechnology. Dr. Moskovits will present on new developments at API Nanotronics in the areas of MEMS (Micro Electro Mechanical Systems) and nanotechnology. Specifically, Dr. Moskovits will discuss the Company's work with nano-optical components and MEMS based actuators and sensors. He will be showcasing the Company's newly introduced line of proprietary UV polarizers fabricated at the Company's NanoOpto facilities using patented nanowire technology.
"We are proud of the Company's achievements in Nanotechnology at this early stage of development," stated Phillip DeZwirek, Chairman and CEO of API. "It is an honor for the industry to recognize API's capabilities and invite us to discuss our accomplishments at this prestigious gathering of industry and the scientific community."
About API Nanotronics Corp.
API Nanotronics Corp., through its wholly owned subsidiaries API Electronics Inc., National Hybrid Inc., Filtran Group, TM Systems, Keytronics and API Nanofabrication and Research Corporation, is engaged in the manufacture of electronic components and systems for the defense and communications industries. API is also developing a leadership position in the R&D and manufacture of nanotechnology and MEMS products. With a growing list of blue chip customers, including Honeywell/Allied Signal, General Dynamics, Lockheed Martin, and numerous other top technology-based firms around the world, API regularly ships products to clients in more than 34 countries. API owns state-of-the-art manufacturing and technology centers in New York, New Jersey, Florida and Ontario, Canada and has manufacturing capabilities in China and a distribution center in Britain. API Nanotronics trades on the OTC Bulletin Board under the symbol APIO. For further information, please visit the company website at http://www.apinanotronics.com
Safe Harbor for Forward-Looking Statements:
Except for statements of historical fact, the information presented herein constitutes forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors over which API Nanotronics Corp. and its subsidiaries and affiliates have little or no control.
For more information, please click here
Director of Corporate Communications for API Nanotronics
TEL: 1-877-API-O-API (274-0274)
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Heat makes electrons’ spin in magnetic superconductors April 26th, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015